Medtronic acquired insulin pen startup Companion Medical to broaden its diabetes management tech.
And competitors like Abbott will likely try to keep pace with moves toward creating an artificial pancreas.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,